Elevated Blood and Urinary ICAM-1 is a Biomarker for Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis

References

• Abd-Elkareem MI, Al Tamimy HM, Khamis OA, et al. (2010). Increased urinary levels of the leukocyte adhesion molecules ICAM-1 and VCAM-1 in human lupus nephritis with advanced renal histological changes: preliminary findings. Clin Exp Nephrol, 14, 548–557. doi:10.1007/s10157-010-0322-z
   PubMed Web of Science ®Google Scholar
• Baraczka K, Nekam K, Pozsonyi T, et al. (2001). Concentration of soluble adhesion molecules (sVCAM-1, sICAM-1 and sL-selectin) in the cerebrospinal fluid and serum of patients with multiple sclerosis and systemic lupus erythematosus with central nervous involvement. Neuroimmunomodulation, 9, 49–54. doi:10.1159/000049007
   PubMed Web of Science ®Google Scholar
• Batuca JR, Ames PR, Amaral M, et al. (2009). Anti-atherogenic and anti-inflammatory properties of high-density lipoprotein are affected by specific antibodies in systemic lupus erythematosus. Rheumatology, 48, 26–31. doi:10.1093/rheumatology/ken397
   PubMed Web of Science ®Google Scholar
• Bhallil O, Ibrahimi A, Ouadghiri S, et al. (2017). HLA class II with lupus nephritis in moroccan patients. Immunol Invest, 46, 1–9. doi:10.1080/08820139.2016.1208218
   PubMed Web of Science ®Google Scholar
• Bloom BJ, Miller LC, Blier PR. (2002). Soluble adhesion molecules in pediatric rheumatic diseases. J Rheumatol, 29, 832–836.
   PubMed Web of Science ®Google Scholar
• Egerer K, Feist E, Rohr U, et al. (2000). Increased serum soluble CD14, ICAM-1 and E-selectin correlate with disease activity and prognosis in systemic lupus erythematosus. Lupus, 9, 614–621. doi:10.1191/096120300678828749
   PubMed Web of Science ®Google Scholar
• Elwy MA, Galal ZA, Hasan HE. (2010). Immunoinflammatory markers and disease activity in systemic lupus erythematosus: something old, something new. East Mediterr Health J, 16, 893–900.
   PubMedGoogle Scholar
• Evi V, Zvezdanovi L, Osi V, et al. (2010). Serum levels and in vitro production of Th1- and Th2-type cytokines by peripheral blood mononuclear cells in patients suffering from systemic lupus erythematosus. J Med Biochem, 29, 19–27. doi:10.2478/v10011-010-0005-z
   Web of Science ®Google Scholar
• Gu MM, Wang XP, Cheng QY, et al. (2019). A Meta-Analysis of Cardiovascular Events in Systemic Lupus Erythematosus. Immunol Invest, 8, 1–6. doi:10.1080/08820139.2019.1567534
   Google Scholar
• Guan J, Wang G, Tam LS, et al. (2012). Urinary sediment ICAM-1 level in lupus nephritis. Lupus, 21, 1190–1195. doi:10.1177/0961203312451334
   PubMed Web of Science ®Google Scholar
• Howe HS, Kong KO, Thong BY, et al. (2012). Urine sVCAM-1 and sICAM-1 levels are elevated in lupus nephritis. Int J Rheum Dis, 15, 13–16. doi:10.1111/j.1756-185X.2012.01720.x
   PubMed Web of Science ®Google Scholar
• Hozo SP, Djulbegovic B, Hozo I. (2005). Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol, 5, 13. doi:10.1186/1471-2288-5-27
   PubMedGoogle Scholar
• Jander S, Heidenreich F, Stoll G. (1993). Serum and CSF levels of soluble intercellular adhesion molecule-1 (ICAM-1) in inflammatory neurologic diseases. Neurology, 43, 1809–1813. doi:10.1212/wnl.43.9.1809
   PubMed Web of Science ®Google Scholar
• Johnson AE, Gordon C, Palmer RG, Bacon PA. (1995). The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum, 38, 551–558.
   PubMed Web of Science ®Google Scholar
• Kluz J, Kopec W, Jakobsche-Policht U, Adamiec R. (2009). Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis. Int Angiol, 28, 192–201.
   PubMed Web of Science ®Google Scholar
• Liu CW, Lee TL, Chen YC, et al. (2018). PM2.5-induced oxidative stress increases intercellular adhesion molecule-1 expression in lung epithelial cells through the IL-6/AKT/STAT3/NF-κB-dependent pathway. Part Fibre Toxicol, 15, 4. doi:10.1186/s12989-018-0240-x
   PubMed Web of Science ®Google Scholar
• Luo D, Wan X, Liu J, Tong T. (2018). Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res, 27, 1785–1805. doi:10.1177/0962280216669183
   PubMed Web of Science ®Google Scholar
• Ma ZJ, Zhao H, Wang YH, et al. (2007). Changes and significance of Serum soluble Intercellular Adhesion Molecule-1 and cytokines in patients with systemic Lupus Erythematosus. Lab Med, 22, 339–341.
   Google Scholar
• Machold KP, Kiener HP, Graninger W, Graninger WB. (1993). Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Immunol Immunopathol, 68, 74–78.
   PubMedGoogle Scholar
• Mahayidin H, Yahya NK, Wan Ghazali WS, et al. (2016). Evaluation of endothelial cell adhesion molecules and Anti-C1q antibody in discriminating between active and non-active systemic lupus erythematosus. Malays J Med Sci, 23, 22–31.
   PubMed Web of Science ®Google Scholar
• Manzi S, Wasko MC. (2000). Inflammation-mediated rheumatic diseases and atherosclerosis. Ann Rheum Dis, 59, 321–325. doi:10.1136/ard.59.5.321
   PubMed Web of Science ®Google Scholar
• Mason JC, Kapahi P, Haskard DO. (1993). Detection of increased levels of circulating intercellular adhesion molecule 1 in some patients with rheumatoid arthritis but not in patients with systemic lupus erythematosus. Lack of correlation with levels of circulating vascular cell adhesion molecule 1. Arthritis Rheum, 36, 519–527.
   PubMed Web of Science ®Google Scholar
• Molad Y, Miroshnik E, Sulkes J, et al. (2002). Urinary soluble VCAM-1 in systemic lupus erythematosus: a clinical marker for monitoring disease activity and damage. Clin Exp Rheumatol, 20, 403–406.
   PubMed Web of Science ®Google Scholar
• Mrowka C, Sieberth HG. (1994). Circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in systemic vasculitis: marked differences between Wegener’s granulomatosis and systemic lupus erythematosus. Clin Investig, 72, 762–768.
   PubMedGoogle Scholar
• Nyberg F, Acevedo F, Stephansson E. (1997). Different patterns of soluble adhesion molecules in systemic and cutaneous lupus erythematosus. Exp Dermatol, 6, 230–235.
   PubMed Web of Science ®Google Scholar
• Pan HF, Leng RX, Wu GC, Ye DQ. (2018). Advance in epidemiologic studies on major autoimmune diseases. Chin J Dis Control Prev, 22(1093–5), 1105.
   Google Scholar
• Pope 3rd CA, Bhatnagar A, McCracken JP, et al. (2016). Exposure to fine particulate air pollution is associated with endothelial injury and systemic inflammation. Circ Res, 119, 1204–1214. doi:10.1161/CIRCRESAHA.116.309279
   PubMed Web of Science ®Google Scholar
• Ridker PM, Hennekens CH, Roitman-Johnson B, et al. (1998). Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet, 351, 88–92. doi:10.1016/S0140-6736(97)09032-6
   PubMed Web of Science ®Google Scholar
• Sabry AA, Elbasyouni SR, Kalil AM, et al. (2006). Markers of inflammation and atherosclerosis in Egyptian patients with systemic lupus erythematosus. Nephrology, 11, 329–335. doi:10.1111/j.1440-1797.2006.00573.x
   PubMed Web of Science ®Google Scholar
• Santos MJ, Carmona-Fernandes D, Canhao H, et al. (2012). Early vascular alterations in SLE and RA patients–a step towards understanding the associated cardiovascular risk. PLoS One, 7, e44668. doi:10.1371/journal.pone.0044668
   PubMed Web of Science ®Google Scholar
• Shen S. (2013). Expression of ICAM-1 and VCAM-1 in Urine of Patients with Systemic Lupus Erythematosus and Its Clinical Significance. Soochow University. Retreived from: http://cdmd.cnki.com.cn/Article/CDMD-10285-1013230795.htm
   Google Scholar
• Smith PP, Gordon C. (2010). Systemic lupus erythematosus: clinical presentations. Autoimmun Rev, 10, 43–45. doi:10.1016/j.autrev.2010.08.016
   PubMed Web of Science ®Google Scholar
• Spronk PE, Bootsma H, Huitema MG, et al. (1994). Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study. Clin Exp Immunol, 97, 439–444. doi:10.1111/j.1365-2249.1994.tb06107.x
   PubMed Web of Science ®Google Scholar
• Tesar V, Masek Z, Rychlik I, et al. (1998). Cytokines and adhesion molecules in renal vasculitis and lupus nephritis. Nephrol Dial Transplant, 13, 1662–1667. doi:10.1093/ndt/13.7.1662
   PubMed Web of Science ®Google Scholar
• Tso TK, Huang WN. (2007). Elevated soluble intercellular adhesion molecule-1 levels in patients with systemic lupus erythematosus: relation to insulin resistance. J Rheumatol, 34, 726–730.
   PubMed Web of Science ®Google Scholar
• Tulek N, Aydintug O, Ozoran K, et al. (1996). Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with systemic lupus erythematosus. Clin Rheumatol, 15, 47–50.
   PubMed Web of Science ®Google Scholar
• Van de Stolpe A, Van der Saag PT. (1996). Intercellular adhesion molecule-1. J Mol Med, 74, 13–33.
   PubMed Web of Science ®Google Scholar
• Wais T, Fierz W, Stoll T, Villiger PM. (2003). Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission. J Rheumatol, 30, 2133–2139.
   PubMed Web of Science ®Google Scholar
• Wan X, Wang W, Liu J, Tong T. (2014). Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol, 14, 135. doi:10.1186/1471-2288-14-135
   PubMed Web of Science ®Google Scholar
• Wang Y, Tao Y, Liu Y, et al. (2018). Rapid detection of urinary soluble intercellular adhesion molecule-1 for determination of lupus nephritis activity. Medicine, 97, e11287. doi:10.1097/MD.0000000000011287
   PubMed Web of Science ®Google Scholar
• Wu C, Yang M, Zhou Z, et al. (2015). Urine adhesion molecule: a marker of active lupus nephritis. Nan Fang Yi Ke Da Xue Xue Bao, 35, 1272–1276.
   PubMedGoogle Scholar
• Wuthrich RP. (1994). Cell adhesion molecules and inflammatory renal diseases. Nephrol Dial Transplant, 9, 1063–1065. doi:10.1093/ndt/9.8.1063
   PubMed Web of Science ®Google Scholar
• Yokoyama H, Takaeda M, Wada T, et al. (1997). Glomerular ICAM-1 expression related to circulating TNF-alpha in human glomerulonephritis. Nephron, 76, 425–433. doi:10.1159/000190225
   PubMed Web of Science ®Google Scholar
• Zaccagni H, Fried J, Cornell J, et al. (2004). Soluble adhesion molecule levels, neuropsychiatric lupus and lupus-related damage. Front Biosci, 9, 1654–1659.
   PubMed Web of Science ®Google Scholar
• Zhang SX, Shao FL, Su LN, Zhang Q. (2008). The role of anti-endothelial cell antibody and intercellular adhesion molecule-1 in the pathogenesis of systemic lupus erythematosus. ShanDong Med, 48, 77–78.
   Google Scholar